Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Cash from Financing Activities (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed Cash from Financing Activities for 6 consecutive years, with $15.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities changed N/A year-over-year to $15.3 million, compared with a TTM value of $18.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $18.0 million, changed N/A over the prior year.
  • Cash from Financing Activities was $15.3 million for Q4 2025 at Alignment Healthcare, up from $948000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $363.7 million in Q1 2021 and bottomed at -$3.5 million in Q2 2021.
  • Average Cash from Financing Activities over 5 years is $34.2 million, with a median of $181000.0 recorded in 2025.
  • Peak annual rise in Cash from Financing Activities hit 164860.0% in 2024, while the deepest fall reached 1216.67% in 2024.
  • Year by year, Cash from Financing Activities stood at -$3.5 million in 2021, then soared by 85.07% to -$527000.0 in 2022, then surged by 105.69% to $30000.0 in 2023, then surged by 164860.0% to $49.5 million in 2024, then crashed by 69.09% to $15.3 million in 2025.
  • Business Quant data shows Cash from Financing Activities for ALHC at $15.3 million in Q4 2025, $948000.0 in Q3 2025, and $1.6 million in Q2 2025.